Hepatitis A

• Hepatitis A virus prevention and vaccination within and outside the VHA in light of recent outbreaks.
  Moon A, Lowy E, Maier M, et al. Fed Pract. 2018 March;35(2):S32-S37.

Hepatitis B

• Prevalence of Hepatitis B Virus Exposure in the Veterans Health Administration and Association With Military-related Risk Factors.
  Beste LA, Ioannou GN, Chang MF et al. Clinical Gastroenterology and Hepatology, 2019.
• Achieving excellence in hepatitis B virus care for Veterans in the VHA.
  Chartier M, Maier M, Morgan T, et al. Fed Pract. 2018 March;35(2):S49-S52.
• Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals.
  Belperio PS, Shahoumian TA, Mole LA, et al. Hepatology. 2017 Jul;66(1):27-36.
• Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
  Hunt CM, Beste LA, Lowy E, et al. World J Gastroenterol. 2016 May 21;22(19):4732-40. (scholarly work supported by VA Liver Disease Database)

Hepatitis C

Epidemiology and Natural Science

• Current state of hepatitis C care in the VA.
  Backus L, Dickson D, Ho S, et al. Fed Pract. 2018 March;35(2):S8-S12.
• Elevated prevalence of hepatitis C infection in users of United States veterans medical centers
  Dominitz JA, et al. Hepatology. 2005;41:88-96.
• Hepatitis C tested prevalence and comorbidities among veterans in the US Northwest
  Sloan KL, et al. J Clin Gastroenterol. 2004 Mar;38(3):279-84.

Testing and Counseling

• Hepatitis C virus screening and prevalence among US veterans in Department of Veterans Affairs care
  Backus LI, Belperio PS, Loomis TP, et al. JAMA Intern Med. 2013 Sep 9;173(16):1549-52.

Clinical Management

• Utilizing clinical pharmacist specialist to manage hepatitis C virus patients on direct-acting antiviral therapy.
  Mikolas LA, Jacques K, Huq M, et al. J Pharm Pract. 2018 Jan 1:897190018777345.
• Curing hepatitis C virus infection: best practices from the U.S. Department of Veterans Affairs.
  Belperio PS, Chartier M, Ross DB, et al. Ann Intern Med. 2017 Oct 3;167(7):499-504.
• Impact of sustained virologic response with direct-acting antiviral treatment on mortality in patients with advanced liver disease.
  Backus LI, Belperio PS, Shahoumian TA, et al. Hepatology. 2017 Jul 27. [Epub ahead of print].
• Primary care physician perspectives on hepatitis C management in the era of direct-acting antiviral therapy.
  Thomson M, Konerman MA, Choxi H, et al. Dig Dis Sci. 2016 Mar 8. [Epub ahead of print].

Treatment

• Strategy Configurations Directly Linked to Higher HCV Treatment Starts: An Applied Use of Configurational Comparative Methods.
  Yakovchenko V, Miech EJ, Chinman M, Chartier M, Gonzalez R, Kirchner JE, Morgan T, Park A, Powell BJ, Proctor EK, Ross D, Waltz TJ, Rogal S. Med Care.2020 May;58(5):e31-e38.
• Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals.
  Belperio PS, Shahoumian TA, Mole LA, et al. Hepatology. 2017 Jul;66(1):27-36.
• Effectiveness of sofosbuvir, ledipasvir/sofosbuvir, or paritaprevir/ritonavir/ombitasvir and dasabuvir regimens for treatment of patients with hepatitis C in the Veterans Affairs National Health Care System.
  Ioannou GN, Beste LA, Chang MF, et al. Gastroenterology. 2016 Sep;151(3):457-471.e5.

Hepatitis C and Associated Diseases

• Hepatitis C-Related Hepatocellular Carcinoma Incidence in the Veterans Health Administration After Introduction of Direct-Acting Antivirals.
  Beste LA, Green P, Berry K, Belperio P, Ioannou GN. JAMA. 2020;324(10):1003-1005.
• Integrating care for patients with chronic liver disease and mental health and substance use disorders.
  Patel K, Maguire E, Chartier M, et al. Fed Pract. 2018 March;35(2):S14-S23.
• Improvement in glycemic control of type 2 diabetes after successful treatment of hepatitis C virus.
  Hum J, Jou JH, Green PK, et al. Diabetes Care. 2017 Sep;40(9):1173-1180.

HIV Coinfection

• The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection
  Ioannou GN, Bryson CL, Weiss NS, et al. Hepatology. 2013 Jan;57(1):249-57.

Cirrhosis

• Impact of Alcohol Use Disorder Treatment on Clinical Outcomes among Patients with Cirrhosis.
  Rogal S, Youk A, Zhang H, Gellad WF, Fine MJ, Good CB, Chartier M, DiMartini AF, Morgan T, Bataller R, Kraemer K. Hepatology. 2020 Jun;71(6):2080-2092
• Access to Comprehensive Services for Advanced Liver Disease in the Veterans Health Administration.
  Dunn SH, Rogal SS, Maier MM et al. Dig Dis Sci. 2019 Dec;64(12):3471-3479.
• Trends in 30-day and 1-year mortality among patients hospitalized with cirrhosis from 2004 to 2013.
  Kanwal F, Tansel A, Kramer JR, et al. Am J Gastroenterol. 2017 Aug;112(8):1287-1297.
• Use of antibiotics among patients with cirrhosis and upper gastrointestinal bleeding is associated with reduced mortality.
  Moon AM, Dominitz JA, Ioannou GN, et al. Clin Gastroenterol Hepatol. 2016 Jun 14. [Epub ahead of print] (scholarly work supported by VA Liver Disease Database)
• Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
  Beste LA, Leipertz SL, Green PK, et al. Gastroenterology. 2015 Nov;149(6):1471-1482.(scholarly work supported by VA Liver Disease Database)
• Management of varices and variceal hemorrhage in cirrhosis
  Garcia-Tsao, G, and Bosch, J. N Engl J Med. 2010 Mar 4;362(9):823-32.

Hepatocellular Carcinoma

• Hepatitis C-Related Hepatocellular Carcinoma Incidence in the Veterans Health Administration After Introduction of Direct-Acting Antivirals.
  Beste LA, Green P, Berry K, Belperio P, Ioannou GN. JAMA. 2020;324(10):1003-1005.
• Effectiveness of hepatitis C antiviral treatment in a USA cohort of veteran patients with hepatocellular carcinoma.
  Beste LA, Green PK, Berry K, et al. J Hepatol. 2017 Jul;67(1):32-39.
• Association of provider specialty and multidisciplinary care with hepatocellular carcinoma treatment and mortality.
  Serper M, Taddei TH, Mehta R, et al; VOCAL Study Group. Gastroenterology. 2017 Jun;152(8):1954-1964.
• Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis.
  Goldberg DS, Taddei TH, Serper M, et al. Hepatology. 2017 Mar;65(3):864-874.
• Hepatocellular carcinoma surveillance: The road ahead.
  Hernaez R, El-Serag HB. Hepatology. 2017 Mar;65(3):771-773.
• Current concepts: hepatocellular carcinoma
  El-Serag, HB. N Engl J Med 2011;365:1118-27.
• Hepatocellular Carcinoma in Veterans: Are We Prepared for an Epidemic?
  Pocha, C. Fed Practitioner. 2010 July; 27: Suppl(6).

Transgender Patients

• Mental health and medical health disparities in 5135 transgender veterans receiving healthcare in the Veterans Health Administration: a case-control study
  Brown GR, Jones KT. LGBT Health. 2015 Dec 16. [Epub ahead of print]